Contact Us

SEC Filings

Investor Contacts

Jeff Macdonald
Executive Director,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717

SEC Filings

Filing date	Form	Description	Filing Group	View
Dec 23, 2013	SC TO-T	Tender offer schedule and amendment filed by a third party.	Mergers & Acquisitions	View HTML 0001193125-13-481906.pdf 0001193125-13-481906.rtf 0001193125-13-481906.xls
Dec 20, 2013	SC TO-C	Written public communication relating to an issuer or third party tender offer	Mergers & Acquisitions	View HTML 0001193125-13-479867.pdf 0001193125-13-479867.rtf 0001193125-13-479867.xls
Dec 20, 2013	8-K/A	Amendment to a previously filed 8-K	Current Reports	View HTML 0001193125-13-481242.pdf 0001193125-13-481242.rtf 0001193125-13-481242.xls
Dec 20, 2013	SC TO-C	Written public communication relating to an issuer or third party tender offer	Mergers & Acquisitions	View HTML 0001193125-13-481243.pdf 0001193125-13-481243.rtf 0001193125-13-481243.xls
Dec 19, 2013	SC TO-C	Written public communication relating to an issuer or third party tender offer	Mergers & Acquisitions	View HTML 0001193125-13-479285.pdf 0001193125-13-479285.rtf 0001193125-13-479285.xls
Dec 19, 2013	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001193125-13-479283.pdf 0001193125-13-479283.rtf 0001193125-13-479283.xls
Dec 13, 2013	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001232524-13-000118.pdf 0001232524-13-000118.rtf
Dec 11, 2013	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001232524-13-000117.pdf 0001232524-13-000117.rtf
Dec 09, 2013	UPLOAD	UPLOAD	Other	View HTML 0000000000-13-066916.pdf
Nov 15, 2013	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001232524-13-000116.pdf 0001232524-13-000116.rtf

Data provided by Kaleidoscope.